LICENSE, RESEARCH AND COLLABORATION AGREEMENT This License, Research and Collaboration Agreement is entered into as of the 13th day of December, 1996 by and between Apollo Genetics, Inc., a Delaware corporation ("Apollo"), and Endocon, Inc., a...License Agreement • March 17th, 1997 • Apollo Biopharmaceutics Inc • Pharmaceutical preparations • Massachusetts
Exhibit 1 [Form of Underwriting Agreement]Underwriting Agreement • March 17th, 1997 • Apollo Biopharmaceutics Inc • Pharmaceutical preparations • New York
Exhibit 10.15 (Form of Warrant Agreement)Warrant Agreement • March 17th, 1997 • Apollo Biopharmaceutics Inc • Pharmaceutical preparations • New York
WITNESSETHPatent License Agreement • March 17th, 1997 • Apollo Biopharmaceutics Inc • Pharmaceutical preparations
Exhibit 10.17 FINANCIAL ADVISORY AGREEMENT This Agreement is made and entered into as of March __, 1997, between First United Equities Corporation ("First United") and Apollo BioPharmaceutics, Inc., a Delaware corporation, (the "Company"). In...Financial Advisory Agreement • March 17th, 1997 • Apollo Biopharmaceutics Inc • Pharmaceutical preparations • New York
Exhibit 10.16 APOLLO BIOPHARMACEUTICS, INC. ANDRepresentative's Warrant Agreement • March 17th, 1997 • Apollo Biopharmaceutics Inc • Pharmaceutical preparations • New York
LICENSE AND COLLABORATION AGREEMENTLicense and Collaboration Agreement • March 17th, 1997 • Apollo Biopharmaceutics Inc • Pharmaceutical preparations
NEURON LOSS PROTECTION TECHNOLOGY LICENSE AGREEMENTLicense Agreement • March 17th, 1997 • Apollo Biopharmaceutics Inc • Pharmaceutical preparations
CORPORATE RESEARCH AGREEMENT TO ACCOMPANY LICENSE AGREEMENTCorporate Research Agreement • March 17th, 1997 • Apollo Biopharmaceutics Inc • Pharmaceutical preparations • Florida
ROYALTY PURCHASE AGREEMENT BETWEEN NEUROSCIENCE PARTNERS LIMITED PARTNERSHIP BY ITS GENERAL PARTNER, MDS ASSOCIES-NEUROSCIENCE INC. - AND - APOLLO GENETICS, INC. DECEMBER 18, 1996Royalty Purchase Agreement • March 17th, 1997 • Apollo Biopharmaceutics Inc • Pharmaceutical preparations • Massachusetts
APOLLO Genetics May 15, 1996 Robert J. Leonard 37 Atlantic Avenue Swampscott, MA 01907 Dear Robert: This letter sets forth the terms on which Apollo Genetics, Inc. (The "Company") is offering to employ you, initially in a consulting capacity, as Vice...Employment Agreement • March 17th, 1997 • Apollo Biopharmaceutics Inc • Pharmaceutical preparations
APOLLO Genetics May 15, 1996 Robert J. Leonard 37 Atlantic Avenue Swampscott, MA 01907 Dear Robert: This letter sets forth the terms on which Apollo Genetics, Inc. (The "Company") is offering to employ you, initially in a consulting capacity, as Vice President of Business Development, subject to the supervision of, and to have such authority as is delegated to you by, the Chief Executive Officer and the Board of Directors of the Company. You shall devote your business time, attention and energies to the business and interests of the Company. In consideration of the services to be rendered by you hereunder, the Company shall pay you an annual salary of $100,000, payable in accordance with the Company's usual payment practices (the "Base Salary"). The first seven months of your employment shall be on a half-time basis (salary to be adjusted on a pro-rata basis) and employment following that on a full-time basis. Your compensation package shall be reviewed annually. Your employment by the
APOLLO Genetics John J. Curry 859 Washington Street Franklin, MA 02038 November 10, 1996 Dear John: This letter sets forth the terms on which Apollo Genetics, Inc. (The "Company") is offering to employ you in an executive capacity, as Vice President...Employment Agreement • March 17th, 1997 • Apollo Biopharmaceutics Inc • Pharmaceutical preparations
APOLLO Genetics John J. Curry 859 Washington Street Franklin, MA 02038 November 10, 1996 Dear John: This letter sets forth the terms on which Apollo Genetics, Inc. (The "Company") is offering to employ you in an executive capacity, as Vice President of Finance and Administration & Chief Financial Officer, subject to the supervision of, and to have such authority as is delegated to you by, the Chief Executive Officer. You shall devote your entire business time, attention and energies to the business and interests of the Company. In consideration of the services to be rendered by you hereunder, the Company shall pay you an annual salary of $80,000, payable in accordance with the Company's usual payment practices (the "Base Salary"). The first month of your employment shall be on a half-time basis and employment following that on a full-time basis. Subject to the approval of the Compensation Committee of the Board, I am recommending that you also receive incentive stock options (the "Opti
